Gaetano Romano

Summary

Affiliation: Temple University
Country: USA

Publications

  1. Romano G. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells. Drug News Perspect. 2008;21:440-5 pubmed publisher
    ..As it stands, the newly developed technology can be used to engineer useful models for the study of human diseases and development of novel therapeutics. ..
  2. Romano G, Gawlinski A. New frontiers in oncology: Immune checkpoint inhibitors in combination therapy. Drugs Today (Barc). 2017;53:103-115 pubmed publisher
    ..This review discusses the important achievements reported in the field of immuno-oncology, along with a glimpse at future directions. ..
  3. Romano G. Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy. Drugs Today (Barc). 2017;53:501-514 pubmed publisher
    ..This review summarizes the achievements and challenges of various modalities for the isolation, enrichment, analysis and enumeration of CTCs and/or CTM, in order to assess the advancement of the disease and the response to therapy. ..

Detail Information

Publications3

  1. Romano G. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells. Drug News Perspect. 2008;21:440-5 pubmed publisher
    ..As it stands, the newly developed technology can be used to engineer useful models for the study of human diseases and development of novel therapeutics. ..
  2. Romano G, Gawlinski A. New frontiers in oncology: Immune checkpoint inhibitors in combination therapy. Drugs Today (Barc). 2017;53:103-115 pubmed publisher
    ..This review discusses the important achievements reported in the field of immuno-oncology, along with a glimpse at future directions. ..
  3. Romano G. Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy. Drugs Today (Barc). 2017;53:501-514 pubmed publisher
    ..This review summarizes the achievements and challenges of various modalities for the isolation, enrichment, analysis and enumeration of CTCs and/or CTM, in order to assess the advancement of the disease and the response to therapy. ..